Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1

Gene

Volumn 212, Issue 2, 1998, Pages 157-166

  Zhang, Shangao ^a   Pointer, Dawn ^b   Singer, Greg ^b   Feng, Yunfeng ^a   Park, Kathleen ^b   Zhao, Ling Jun ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

DNA; HIV; Interaction; RNA; Vpr

Indexed keywords

DNA; VPR PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G2 PHASE; CHROMATOGRAPHY; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; VIRUS CELL INTERACTION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; GENE PRODUCTS, VPR; GENOME, VIRAL; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACIDS; PROTEIN BINDING; RNA, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032496649     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00178-4     Document Type: Article

References (41)

1. Agostini I., Navarro J.M., Rey F., Bouhamdan M., Spire B., Vigne R., Sire J. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. J. Mol. Biol. 261:1996;599-606.
2. Ayyavoo V., Mahboubi A., Mahalingam S., Ramalingam R., Kudchodkar S., Williams W.V., Green D.R., Weiner D.B. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat. Med. 3:1997;1117-1123.
3. Balliet J.W., Kolson D.L., Eiger G., Kim F.M., McGann K.A., Srinivasan A., Collman R. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology. 200:1994;623-631.
4. Balotta C., Lusso P., Crowley R., Gallo R.C., Franchini G. Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. J. Virol. 67:1993;4409-4414.
5. Bartz S.R., Rogel M.E., Emerman M. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70:1996;2324-2331.
6. Bukrinsky M.I., Haggerty S., Dempsey M.P., Sharova N., Adzhubel A., Spitz L., Lewis P., Goldfarb D., Emerman M., Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature. 365:1993;666-669.
7. Cohen E.A., Dehni G., Sodroski J.G., Haseltine W.A. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64:1990;3097-3099.
8. Cohen E.A., Terwilliger E.F., Jalinoos Y., Proulx J., Sodroski J.G., Haseltine W.A. Identification of HIV-1 vpr product and function. J. AIDS. 3:1990;11-18.
9. Collman R., Balliet J.W., Gregory S.A., Friedman H., Kolson D.L., Nathanson N., Srinivasan A. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66:1992;7517-7521.
10. Cullen B.R. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56:1992;375-394.
11. de Rocquigny H., Petitjean P., Tanchou V., Decimo D., Drouot L., Delaunay T., Darlix J.L., Roques B.P. The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr. J. Biol. Chem. 272:1997;30753-30759.
12. Di Marzio P., Choe S., Ebright M., Knoblauch R., Landau N.R. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69:1995;7909-7916.
13. Fletcher T.M.R., Brichacek B., Sharova N., Newman M.A., Stivahtis G., Sharp P.M., Emerman M., Hahn B.H., Stevenson M. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J. 15:1996;6155-6165.
14. Gibbs J.S., Lackner A.A., Lang S.M., Simon M.A., Sehgal P.K., Daniel M.D., Desrosiers R.C. Progression to AIDS in the absence of a gene for vpr or vpx. J. Virol. 69:1995;2378-2383.
15. Greene W.C. Regulation of HIV-1 gene expression. Annu. Rev. Immunol. 8:1990;453-475.
16. Hattori N., Michaels F., Fargnoli K., Marcon L., Gallo R.C., Franchini G. The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. Proc. Natl. Acad. Sci. USA. 87:1990;8080-8084.
17. He J., Choe S., Walker R., Di Marzio P., Morgan D.O., Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:1995;6705-6711.
18. Heinzinger N.K., Bukinsky M.I., Haggerty S.A., Ragland A.M., Kewalramani V., Lee M.A., Gendelman H.E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
19. Henderson L.E., Sowder R.C., Copeland T.D., Benveniste R.E., Oroszlan S. Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2. Science. 241:1988;199-201.
20. Kewalramani V.N., Park C.S., Gallombardo P.A., Emerman M. Protein stability influences human immunodeficiency virus type 2 Vpr virion incorporation and cell cycle effect. Virology. 218:1996;326-334.
21. Lang S.M.et al. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 67:1993;902-912.
22. Lavallee C., Yao X.J., Ladha A., Gottlinger H., Haseltine W.A., Cohen E.A. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. J. Virol. 68:1994;1926-1934.
23. Levy D.N., Refaeli Y., Weiner D.B. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69:1995;1243-1252.
24. Lu Y.L., Spearman P., Ratner L. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67:1993;6542-6550.
25. Mahalingam S., Ayyavoo V., Patel M., Kieber-Emmons T., Weiner D.B. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J. Virol. 71:1997;6339-6347.
26. Mahalingam S., Patel M., Collman R.G., Srinivasan A. The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles. Virology. 214:1995;647-652.
27. Paxton W., Connor R.I., Landau N.R. Incorporation of Vpr into human immunodeficiency virus type 1 virions, requirement for the p6 region of gag and mutational analysis. J. Virol. 67:1993;7229-7237.
28. Planelles V., Jowett J.B., Li Q.X., Xie Y., Hahn B., Chen I.S. Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70:1996;2516-2524.
29. Re F., Braaten D., Franke E.K., Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69:1995;6859-6864.
30. Rogel M.E., Wu L.I., Emerman M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:1995;882-888.
31. Sato A., Yoshimoto J., Isaka Y., Miki S., Suyama A., Adachi A., Hayami M., Fujiwara T., Yoshie O. Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion. Virology. 220:1996;208-212.
32. Stewart S.A., Poon B., Jowett J.B., Chen I.S. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71:1997;5579-5592.
33. Wang L., Mukherjee S., Jia F., Narayan O., Zhao L.J. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J. Biol. Chem. 270:1995;25564-25569.
34. Wang L., Mukherjee S., Narayan O., Zhao L.J. Characterization of a leucine-zipper-like domain in Vpr protein of human immunodeficiency virus type 1. Gene. 178:1996;7-13.
35. Wong-Staal F., Chanda P.K., Ghrayeb J. Human immunodeficiency virus: the eighth gene. AIDS Res. Hum. Retroviruses. 3:1987;33-39.
36. Wu-Baer F., Lane W.S., Gaynor R.B. Identification of a group of cellular cofactors that stimulate the binding of RNA polymerase II and TRP-185 to human immunodeficiency virus 1 TAR RNA. J. Biol. Chem. 271:1996;4201-4208.
37. Yuan X., Matsuda Z., Matsuda M., Essex M., Lee T.H. Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res. Hum. Retroviruses. 6:1990;1265-1271.
38. Zhang C., Rasmussen C., Chang L.J. Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe. Virology. 230:1997;103-112.
39. Zhao L.J., Mukherjee S., Narayan O. Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein. J. Biol. Chem. 269:1994;15577-15582.
40. Zhao L.J., Narayan O. A gene expression vector useful for protein purification and studies of protein-protein interaction. Gene. 137:1993;345-346.
41. Zhao L.J., Wang L., Mukherjee S., Narayan O. Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. J. Biol. Chem. 269:1994;32131-32137.